179 related articles for article (PubMed ID: 4389304)
1. [Clinical test on the effect of the new antihistaminic preparation HS-592 (Tavegyl, Sandoz)].
Zukowski W; Smolik R; Kmietowicz-Zukowska A; Gruszka S; Kwiatkowski S
Przegl Lek; 1969 Apr; 25(4):379-82. PubMed ID: 4389304
[No Abstract] [Full Text] [Related]
2. A new antihistaminic drug (Tavegyl) in allergic diseases.
Hajós M
Ther Hung; 1971; 19(2):67-9. PubMed ID: 4152119
[No Abstract] [Full Text] [Related]
3. [Evaluation of the clinical usefulness of the antihistamine preparation HS-592 (Tavegyl-Sandoz) in treatment of allergic rhinitis and sinusitis].
Semczuk B; Klonowski S
Pol Tyg Lek; 1970 Feb; 25(8):303-5. PubMed ID: 4392044
[No Abstract] [Full Text] [Related]
4. [Bikarfen--a new Soviet antihistaminic and antiserotonin preparation in the therapy of allergic dermatoses].
Anton'ev AA; Kaminka ME; Absava GI; Poroshina IuA; Ushakov IV
Vestn Dermatol Venerol; 1988; (10):68-72. PubMed ID: 2906194
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of a new antihistaminic: HS-592].
von Bernath Z
Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545
[No Abstract] [Full Text] [Related]
6. [Clinical and allergological evaluation of Tavegil (HS-592), a new antihistaminic drug].
Bogdaszewska-Czabanowska ; Starzycki Z
Przegl Dermatol; 1969; 56(5):659-65. PubMed ID: 4391299
[No Abstract] [Full Text] [Related]
7. [Preliminary clinical experience with a new drug with antihistaminic action (HS 592)].
Corrado Negrini A; Dolcino G
Arch Maragliano Patol Clin; 1967; 23(6):733-47. PubMed ID: 4389860
[No Abstract] [Full Text] [Related]
8. [Further development of terfenadine].
Paul E
Hautarzt; 1997 Aug; 48(8 Suppl):7. PubMed ID: 9378647
[No Abstract] [Full Text] [Related]
9. [Ambulatory testing of a new antihistaminic. Experience with Tavegil].
Weitgasser H
Munch Med Wochenschr; 1967 May; 109(20):1134-6. PubMed ID: 4384702
[No Abstract] [Full Text] [Related]
10. [Therapeutic evaluation of a new antihistaminic: HS-592].
Guimarães NA; Fonseca O
Hospital (Rio J); 1968 Nov; 74(5):1511-4. PubMed ID: 4388711
[No Abstract] [Full Text] [Related]
11. [Clinical evaluation of the antihistaminic activity of a new antihistaminic product with selective and non hypnotic action (HS 592)].
De Caro L; Rizzo SC
Folia Allergol (Roma); 1969; 16(3):234-48. PubMed ID: 4397213
[No Abstract] [Full Text] [Related]
12. [Remove Tavegyl].
Gottberg L
Lakartidningen; 2012 Aug 22-Sep 4; 109(34-35):1483-4. PubMed ID: 22993901
[No Abstract] [Full Text] [Related]
13. [On the antihistaminic effect of pantothenic acid].
Szórády I; Horváth E; Tóth E
Int Z Vitaminforsch; 1966; 36(2):126-33. PubMed ID: 4384045
[No Abstract] [Full Text] [Related]
14. [Experimental and clinical studies of a new histamine antagonist].
Kallós P
Lakartidningen; 1969 Jun; 66():Suppl II:57+. PubMed ID: 4392857
[No Abstract] [Full Text] [Related]
15. [Clinical and experimental studies with the antihistaminic Tavegyl in dermatologic patients].
Grabner K
Wien Klin Wochenschr; 1970 Sep; 82(36):625-7. PubMed ID: 4396798
[No Abstract] [Full Text] [Related]
16. [Clinical experience with HS-592 (a new antihistaminic) for so-called allergic rhinitis].
Baba S; Oashi M; Seno Y; Maruo T
Penn Dent J (Phila); 1970 Mar; 73(2):319-22. PubMed ID: 4192065
[No Abstract] [Full Text] [Related]
17. A new antihistamine hc20-511 compared with dimetinden (fenistil retard) in the treatment of chronic urticaria and other pruritic dermatoses.
Kuokkanen K
Acta Allergol; 1975 Jul; 30(2-3):73-9. PubMed ID: 239517
[TBL] [Abstract][Full Text] [Related]
18. [Case reports in clinical treatment with a synthetic antihistaminic: HS 592].
Giamperi M
Folia Allergol (Roma); 1971; 18(1):69-82. PubMed ID: 4397373
[No Abstract] [Full Text] [Related]
19. A clinical trial of brompheniramine maleate in chronic urticaria.
Warin RP; Moore-Robinson M
Practitioner; 1966 Aug; 197(178):212-4. PubMed ID: 4380315
[No Abstract] [Full Text] [Related]
20. [Experience with a new antihistaminic (Tavegyl, Sandoz) in a dermatologic-allergologic practice].
Wortmann F
Dermatol Wochenschr; 1968 Nov; 154(48):1129-33. PubMed ID: 4389418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
